The changing face of hormonal therapy for prostate cancer

被引：7

作者：

Seruga, B. ^{[1
]}

Tannock, I. F.

机构：

[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

ANDROGEN-DEPRIVATION THERAPY; RANDOMIZED CONTROLLED-TRIAL; PHASE-III TRIAL; RADICAL PROSTATECTOMY; METABOLIC SYNDROME; RADIATION-THERAPY; TESTOSTERONE SUPPRESSION; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; AMERICAN-SOCIETY;

D O I：

10.1093/annonc/mdn477

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：79 / 85

页数：7

共 55 条

[11] The changing face of prostate cancer [J].

Cooperberg, MR ;

Moul, JW ;

Carroll, PR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) :8146-8151

[12]

CORDONCARDO C, 2007, ASCO ANN M P S, V25

[13] Androgen suppression and radiation vs radiation alone for prostate cancer - A randomized trial [J].

D'Amico, Anthony V. ;

Chen, Ming-Hui ;

Renshaw, Andrew A. ;

Loffredo, Marian ;

Kantoff, Philip W. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03) :289-295

[14] Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions [J].

D'Amico, Anthony V. ;

Denham, James W. ;

Crook, Juanita ;

Chen, Ming-Hui ;

Goldhaber, Samuel Z. ;

Lamb, David S. ;

Joseph, David ;

Tai, Keen-Hun ;

Malone, Shawn ;

Ludgate, Charles ;

Steigler, Allison ;

Kantoff, Philip W. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) :2420-2425

[15]

Dalesio O, 2000, LANCET, V355, P1491

[16]

DASILVA FMC, 2006, ASCO ANN M P S, V24

[17]

de Leval Jean, 2002, Clin Prostate Cancer, V1, P163, DOI 10.3816/CGC.2002.n.018

[18] Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial [J].

Denham, JW ;

Steigler, A ;

Lamb, DS ;

Joseph, D ;

Mameghan, H ;

Turner, S ;

Matthews, J ;

Franklin, I ;

Atkinson, C ;

North, J ;

Poulsen, M ;

Christie, D ;

Spry, NA ;

Tai, KH ;

Wynne, C ;

Duchesne, G ;

Kovacev, O ;

D'Este, C .

LANCET ONCOLOGY, 2005, 6 (11) :841-850

[19] Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia [J].

Dockery, F ;

Bulpitt, CJ ;

Agarwal, S ;

Donaldson, M ;

Rajkumar, C .

CLINICAL SCIENCE, 2003, 104 (02) :195-201

[20]

EFSTATHIOU JA, 2008, EUR UROL IN PRESS

← 1 2 3 4 5 6 →